Expression of the p53 proteinwas associated with better prognosis in patients with estrogen-negative tumors but with a worse prognosis for estrogen-positive tumors, according to a study published in the November 5 edition of Breast Cancer Research. The protective value of p53 applies to both triple-negative and Her2-positive breast cancer.